ACR

Novel approach to normalizing immune activity

Small study suggests at least a 10-day holiday

Trial data pave way for FDA approval

Drug targeting B cells as effective as broad-spectrum immunosuppressant in lung disease

Phase II data show good efficacy by objective measures, even with strong placebo effect

Small trial demonstrates big cut in steroid-linked adverse effects

More support for add-on methotrexate to maintain protein drug's efficacy

Local nerve block proves mettle in randomized trial, though benefit didn't last long

Observational study shows excellent efficacy in systemic pediatric arthritis

Phase II trial found sustained remission with steroid-sparing effects

No new safety signals seen in long-term extension for lupus nephritis

Incidence of autoimmune disease decreased by 25-30% with dietary supplements

Skin and joint improvements persisted through 2 years of follow-up

After 2 years, more patients on combo biologic/DMARD regimen had inactive disease